RARA CRAFT DATABASE for FDA Medical Devices
510(k)K211052

FDA DEVICE FACTS

Straumann RidgeFit Implants

Institut Straumann AG

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJuly 8, 2021PRODUCT CODEDZE

Indications for use

Straumann® RidgeFit Implants ∅2.4 mm are for oral endosteal implantation in the upper and/or lower jaw of fully edentulous patients. The implants can be placed with immediate function when primary stability is achieved for all implants or with conventional loading if primary stability is not achieved for all implants. Straumann ® RidgeFit Implants are intended for the stabilization of removable dentures.

• For mandibular restorations, at least 4 Straumann® RidgeFit Implants ∅2.4 mm should be placed.

• For maxillary restorations, at least 6 Straumann® RidgeFit Implants ∅2.4 mm should be placed. Straumann® RidgeFit Implants Straumann USA, LLC July 8, 2021

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026